SCHEMBL4025085

SCHEMBL4025085

O=C(Nc1cccnc1)Nc1ccc(Br)cc1-c1nnn[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
HTT P42858 3/20 0.60
KDM4E B2RXH2 1/20 0.60
MAPK1 P28482 1/20 0.60
MAPT P10636 3/20 0.48
LMNA P02545 2/20 0.46
ATM Q13315 1/20 0.46
SORT1 Q99523 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
FPR2 P25090 2/20 0.44
POLB P06746 1/20 0.44
P2RX4 Q99571 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
GRIK1 P39086 1/20 0.43
KDR P35968 1/20 0.43
AHR P35869 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5472073 0.90 CNR1 (0.50) MEN1KMT2AHTTKDM4EMAPK1
SCHEMBL1463540 0.87 GRIK1 (0.50) MEN1KMT2AHTTKDM4EMAPK1
SCHEMBL1463507 0.85 KMT2A (0.45) MEN1KMT2AHTTKDM4EMAPK1
SCHEMBL1462286 0.83 SMN1; SMN2 (0.54) MEN1KMT2AHTTMAPK1MAPT
SCHEMBL1463226 0.83 MEN1 (0.47) MEN1KMT2AHTTMAPTLMNA
SCHEMBL1463359 0.83 KMT2A (0.58) MEN1KMT2AHTTKDM4EMAPK1
SCHEMBL1463081 0.82 MEN1 (0.47) MEN1KMT2AHTTKDM4EMAPK1
SCHEMBL1463512 0.82 MGLL (0.50) MEN1KMT2AHTTMAPTLMNA
SCHEMBL1463473 0.81 KMT2A (0.46) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL1463395 0.81 KMT2A (0.45) MEN1KMT2AHTTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537075-B1 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2009-07-01 EP claimed
US-20060160856-A1 Diarylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2006-07-20 US claimed
EP-1537075-B1 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2009-07-01 EP disclosed
US-20060160856-A1 Diarylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160856-A1 Diarylurea derivatives and their use as chloride channel blockers KIT, ORAI1, CACNA1C MEN1 1915/4885KMT2A 774/4885HTT 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.